Skip to main content

Advertisement

Log in

Human gross cyst breast disease and cystic fluid: bio-molecular, morphological, and clinical studies

  • Review
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Qui addit scientiam, addit et laborem” “He that increaseth knowledge increaseth also sorrow” (Ecclesiastes 1:18, Bible)

Summary

For more than one and a half century the cystic disease of the breast has been recognized as the most frequent female benign breast lesion. Although some conundrums and controversies exist about the relation between gross cysts and breast cancer, recent evidence suggests that the multidisciplinary study of gross cystic breast disease (GCBD) may be a powerful tool for predicting the natural history of the multifaceted gross cyst pathology. A lot of papers have been published on breast cyst fluids (BCF) concerning biochemical, hormonal and morphological aspects, demonstrating that the intracystic fluid contains a wide variety of components (such as ions, lipids, proteins, enzymes, growth factors and antigens) and suggesting that their profile provides additional knowledge on both physiopathology and etiologic pathways of human gross cystic breast disease. The aim of this overview is the critical evaluation of all data accumulated in the last thirty years, in order to highlight the utility of biochemical and epidemiological studies to identify gross cysts, if any, at higher breast cancer risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cooper AP, 1845. The anatomy and diseases of the breast. Lea and Blanchard, Philadelphia

    Google Scholar 

  2. Reclus P, 1883 La maladie kystique des mamelles Bull Soc Anat Paris 58: 428–433

    Google Scholar 

  3. Schimmelbusch C, 1892 Das cystadenoma der mamma Arch Klin Chir 44: 117–134

    Google Scholar 

  4. Ahmed A, 1978. Atlas of the ultrastructure of human breast diseases. Churchill Livingstone, New York

    Google Scholar 

  5. Bodian CA, 1993 Benign breast diseases, carcinoma in situ, and breast cancer risk Epidem Rev 15: 177–187

    CAS  Google Scholar 

  6. Mannello F, Malatesta M, Gazzanelli G, 1999 Breast cancer in women with palpable breast cysts Lancet 354: 677–678

    PubMed  CAS  Google Scholar 

  7. Frantz VK, Pickren JW, Melcher GW, Auchincloss H Jr., 1951 Incidence of chronic cystic disease in so-called normal breasts: study based on 225 post-mortem examinations Cancer 4: 762–783

    PubMed  CAS  Google Scholar 

  8. Haagensen CD, 1986. Diseases of the breast. WB Saunders Co., Philadelphia

    Google Scholar 

  9. Brenner RJ, Bein ME, Sarti DA, Vinstein AL, 1994 Spontaneous regression of interval benign cysts of the breast Radiology 193: 365–368

    PubMed  CAS  Google Scholar 

  10. Norlock FE, 2002 Benign breast pain in women: a practical approach to evaluation and treatment JAMWA 57: 85–90

    PubMed  Google Scholar 

  11. Santen RJ, Mansel R, 2005 Benign breast disorders N Engl J Med 353: 275–285

    PubMed  CAS  Google Scholar 

  12. Semb C, 1928 Pathological-anatomical and clinical investigations of fibro-adenomatosis cystica mammae and its relation to other pathological conditions in mamma, especially cancer Acta Chir Scandinav 64(Suppl. 10): 1–484

    Google Scholar 

  13. Dixon JM, Mansel RE, 1995 Pigments in breast fluids: What are they? BMJ 310: 402–403

    Google Scholar 

  14. Malatesta M, Mannello F, Sebastiani M, Cardinali A, Marcheggiani F, Renò F, Gazzanelli G, 1998 Ultrastructural characterization and biochemical profile of human gross cystic breast disease Breast Cancer Res Treat 48: 211–219

    PubMed  CAS  Google Scholar 

  15. Love SM, Gelman RS, Silen W, 1982 Fibrocystic disease of the breast: a nondisease? N Engl J Med 307: 1010–1014

    PubMed  CAS  Google Scholar 

  16. Minton JP, Abou-Issa H, Reiches N, Roseman JM, 1981 Clinical and biochemical studies on methylxanthine-related fibrocystic breast disease Surgery 90: 299–304

    PubMed  CAS  Google Scholar 

  17. Horner NK, Lampe JW, 2000 Potential mechanisms of diet therapy for fibrocystic breast conditions show inadequate evidence of effectiveness J Am Diet Assoc 100: 1368–1380

    PubMed  CAS  Google Scholar 

  18. Webb PM, Byrne C, Schnitt SJ, Connolly JL, Jacobs TW, Baer HJ, Willett WC, Colditz GA, 2004 A prospective study of diet and benign breast disease Cancer Epidemiol Biomarkers Prev 13: 1106–1113

    PubMed  Google Scholar 

  19. Michels KB, Holmberg L, Bergkvist L, Wolk A, 2002 Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish women Ann Epidemiol 12: 21–26

    PubMed  Google Scholar 

  20. Dogliotti L, Orlandi F, Caraci P, Puligheddu B, Torta M, Angeli A, 1990 Biochemistry of breast cyst fluid: an approach to understanding intercellular communication in the terminal duct lobular units Ann NY Acad Sci USA 586: 17–28

    CAS  Google Scholar 

  21. Molina R, Filella X, Herranz M, Prats M, Velasco A, Zanon G, Martinez-Osaba MJ, Ballesta AM, 1990 Biochemistry of cyst fluid in fibrocystic disease of the breast: approach to classification and understanding of the mechanism of formation Ann NY Acad Sci USA 586: 29–42

    CAS  Google Scholar 

  22. Angeli A, Dogliotti L, Orland F, Beccati D, 1987 Mammary cysts: pathophysiology and biochemistry Nucl Med Biol 14: 397–406

    CAS  Google Scholar 

  23. Sartorius OW, 1995 The biochemistry of breast cyst fluids and duct secretions Breast Cancer Res Treat 35: 255–266

    PubMed  CAS  Google Scholar 

  24. Dixon JM, Scott WN, Miller WR, 1985 Natural history of cystic disease: importance of cyst type Br J Surg 72: 190–192

    PubMed  CAS  Google Scholar 

  25. Beccati D, Grilli N, Schincaglia P, Naldoni C, Tavolazzi L, Ranaldi R, Dogliotti L, Torta M, Angeli A, 1988 Apocrine cells in breast cyst fluid and their relationship to cyst type: a morphometric study Eur J Cancer Clin Oncol 24: 597–602

    PubMed  CAS  Google Scholar 

  26. Naldoni C, Bruzzi P, Bucchi S, Gordini M, Torta M, Caraci P, Orlandi F, 1990 Cohort study of women affected by gross cystic disease: correlation between cationic and hormonal composition of breast cyst fluid and the risk of breast cancer Ann NY Acad Sci USA 586: 272–275

    CAS  Google Scholar 

  27. Vizoso F, Fueyo A, Allende MT, Fernandez J, Garcia-Moran M, Ruibal A, 1990 Evaluation of human breast cysts according to their biochemical and hormonal composition, and cytological examination Eur J Surg Oncol 16: 209–214

    PubMed  CAS  Google Scholar 

  28. Dixon JM, Miller WR, Scott WN, 1983 The morphological basis of human breast cyst populations Br J Surg 70: 604–606

    PubMed  CAS  Google Scholar 

  29. Ebbs SR, Bates T, 1988 Breast cyst type does not predict the natural history of cystic disease or breast cancer Br J Surg 75: 702–704

    PubMed  CAS  Google Scholar 

  30. Angeli A, Bradlow HL, Bodian CA, Chasalow FI, Dogliotti L, Haagensen DE Jr., 1990 Criteria for classifying breast cyst fluids Ann NY Acad Sci USA 586: 49–53

    CAS  Google Scholar 

  31. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton III LJ, Visscher DW, 2005 Benign breast disease and the risk of breast cancer N Engl J Med 353: 229–237

    PubMed  CAS  Google Scholar 

  32. Krieger N, Hiatt RA, 1992 Risk of breast cancer after benign breast disease Am J Epidemiol 135: 619–631

    PubMed  CAS  Google Scholar 

  33. Ciatto S, Biggeri A, Rosselli Del Turco M, Bartoli D, Iossa A, 1990 Risk of breast cancer subsequent to proven gross cystic disease Eur J Cancer 26: 555–557

    PubMed  CAS  Google Scholar 

  34. Naldoni C, Costantini M, Dogliotti L, Bruzzi P, Bucchi L, Buzzi G, Torta M, Angeli A, 1992 Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast Cancer Res 52: 1791–1795

    PubMed  CAS  Google Scholar 

  35. Hodge J, Surver J, Aponte GG, 1959 Relationship of fibrocystic disease to carcinoma of breast; study based on 876 cases AMA Arch Surg 79: 670–678

    PubMed  CAS  Google Scholar 

  36. Page DL, Van der Zwaag R, Rogers LW, Williams LT, Walker WE, Hartmann WH, 1978 Relation between component parts of fibrocystic disease complex and breast cancer J Natl Cancer Inst 61: 1055–1063

    PubMed  CAS  Google Scholar 

  37. Harrington LE, Lesnick G, 1981 The association between gross cysts of the breast and breast cancer Breast 7: 113–117

    Google Scholar 

  38. Campbell OJ, 1934 Relationship between cystic disease of breast and carcinoma Arch Surg 28: 1001–1056

    Google Scholar 

  39. Foote FW, Stewart FW, 1945 Comparative studies of cancerous versus noncancerous breasts Ann Surg 121: 6–53

    PubMed  CAS  Google Scholar 

  40. Potter JF, Slimbaugh WP, Woodward SC, 1968 Can breast be anticipated?: a follow-up of benign breast biopsies Ann Surg 167: 829–838

    PubMed  CAS  Google Scholar 

  41. Gallager HS, Martin JE, 1969 Early phases in the development of breast cancer Cancer 24: 1170–1178

    PubMed  CAS  Google Scholar 

  42. Black MM, Barclay THC, Cutler SJ, Hankey BF, Asire AJ, 1972 Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer Cancer 29: 338–343

    PubMed  CAS  Google Scholar 

  43. Jensen HM, Rice JR, Wellings SR, 1976 Preneoplastic lesions in the human breast Science 191: 295–297

    PubMed  CAS  Google Scholar 

  44. Dupont WD, Page DL, 1985 Risk factors for breast cancer in women with proliferative breast disease N Engl J Med 312: 146–151

    PubMed  CAS  Google Scholar 

  45. Page DL, Dupont WD, 1985 Are breast cysts a premalignant marker? Eur J Clin Oncol 21:635–636

    Google Scholar 

  46. Cancer Committee of the College of American Pathologists: Is “fibrocystic disease” of the breast precancerous? Arch Pathol Lab Med 110: 171–173, 1986

    Google Scholar 

  47. Warren S, 1940. Relation of “chronic mastitis” to carcinoma of breast Surg Gynec Obst 71: 257–273

    Google Scholar 

  48. Clagett OT, Plimpton NC, Root GT, 1944 Lesions of breast: relationship of benign lesions to carcinoma Surgery 15: 413–419

    Google Scholar 

  49. Davis HH, Simons M, Davis JB, 1964 Cystic disease of the breast: relationship to carcinoma Cancer 17: 957–978

    PubMed  CAS  Google Scholar 

  50. Veronesi U, Pizzocaro G. 1968 Breast cancer in women subsequent to cystic disease of the breast Surg Gynecol Obstet 126: 529–532

    PubMed  CAS  Google Scholar 

  51. Chardot C, Varroyi A, Parach RM, 1970 Mastose fibro-kystique et cancer Bull Cancer 57: 251–268

    PubMed  CAS  Google Scholar 

  52. Donnelly PK, Baker KW, Carney JA, O’Fallon WM, 1975 Benign breast lesions and subsequent breast carcinoma in Rochester, Minnesota Mayo Clin Proc 50: 650–656

    PubMed  CAS  Google Scholar 

  53. Kodlin D, Winger EE, Morgenstern NL, Chen U, 1977 Chronic mastopathy and breast cancer: a follow-up study Cancer 39: 2603–2607

    PubMed  CAS  Google Scholar 

  54. Hutchinson WB, Thomas DB, Hamlin WB, Roth GJ, Peterson AV, Williams B, 1980 Risk of breast cancer in women with benign breast disease J Natl Cancer Inst 65:13–20

    PubMed  CAS  Google Scholar 

  55. Jones BM, Bradbeer JW, 1980 The presentation and progress of macroscopic breast cysts Br J Surg 67: 69–71

    Google Scholar 

  56. Roberts MM, Jones V, Elton RA, 1984 Risk of breast cancer in women with a history of benign disease of the breast BMJ 288: 275–278

    PubMed  CAS  Google Scholar 

  57. Brinton LA, 1990 Relationship of benign breast disease to breast cancer Ann NY Acad Sci 586: 266–271

    PubMed  CAS  Google Scholar 

  58. Bundred NJ, West RR, O’Dowd J, Mansel RE, 1991 Is there an increased risk of breast cancer in women who have had a breast cyst aspirated? Br J Cancer 64: 953–955

    PubMed  CAS  Google Scholar 

  59. Bruzzi P, Bucchi L, Costantini M, Naldoni C, 1990 Follow-up studies of patients with categorized breast cysts: methodological issues Ann NY Acad Sci 586: 43–48

    PubMed  CAS  Google Scholar 

  60. Dixon JM, McDonald C, Elton RA, Miller WR, 1999 Risk of breast cancer in women with palpable breast cysts: a prospective study Lancet 353: 1742–1745

    PubMed  CAS  Google Scholar 

  61. Budai B, Számel I, Sulyok Z, Német M, Bak M, Ottò SZ, Reed MJ, Purohit A, Parish DC, Kralovanszky J, 2001 Characteristics of cystic breast disease with special regard to breast cancer development Anticancer Res 21: 749–752

    PubMed  CAS  Google Scholar 

  62. Enriori CL, Novelli JE, Cremona MC, Hirsig RJP, Enriori PJ, 1992 Biochemical study of cyst fluid in human breast cystic disease: a review Breast Cancer Res Treat 24: 1–8

    PubMed  CAS  Google Scholar 

  63. Dixon JM, Lumsden AB, Miller WR, 1985 The relationship of cyst type to risk factors for breast cancer and the subsequent development of breast cancer in patients with breast cystic disease Eur J Cancer Clin Oncol 21: 1047–1050

    PubMed  CAS  Google Scholar 

  64. Hutter RVP, 1985 Good-bye to fibrocystic disease N Engl J Med 312:179–181

    PubMed  CAS  Google Scholar 

  65. Baum M, 1999 Breast cancer in women with palpable breast cysts Lancet 354: 677

    PubMed  CAS  Google Scholar 

  66. Papanicolaou GN, Holmquist DG, Bader BM, Falk EA, 1958 Exfoliative cytology of human mammary gland and its value in diagnosis of cancer and other diseases of breast Cancer 11: 377–409

    PubMed  CAS  Google Scholar 

  67. Dabbs D, 1993 Mammary ductal foam cells: macrophage immunophenotype Human Pathol 24:977–981

    CAS  Google Scholar 

  68. Zanardi S, Valenti G, Torrisi R, Maisto L, Nicolò G, Barreca A, Minuto F, Boccardo F, 1991 Identification of breast cyst subpopulations: biochemical and morphological features Cancer Detect Prev 15: 273–276

    PubMed  CAS  Google Scholar 

  69. Tsung JSH, Wang TY, Wang SM, Yang PS, 2005 Cytological and biochemical studies of breast cyst fluid. Breast 14: 37–41

    PubMed  CAS  Google Scholar 

  70. Cowen PN, Benson EA, 1979 Cytological study of fluid from breast cysts Br J Surg 66: 209–211

    PubMed  CAS  Google Scholar 

  71. Ciatto S, Cariaggi P, Bulgaresi P, 1987 The value of routine cytologic examination of breast cyst fluids Acta Cytol 31: 301–304

    PubMed  CAS  Google Scholar 

  72. Hindle WH, Arias RD, Florentine B, Whang J, 2000 Lack of utility in clinical practice of cytologic examination of nonbloody cyst fluid from palpable breast cysts Am J Obstet Gynecol 182: 1300–1305

    PubMed  CAS  Google Scholar 

  73. Tabar L, Pentek Z, Dean PB, 1981 The diagnostic and therapeutic value of breast cyst puncture and pneumocystography Radiology 141: 659–663

    PubMed  CAS  Google Scholar 

  74. Stella F, Biagioni S, Stella C, Cerroni L, Troccoli R, 1984 La citologia delle cisti mammarie Quad Sclavo Diagn 20: 283–294

    PubMed  CAS  Google Scholar 

  75. Toth J, Szamel I, Svastic E, DeSombre ER, 1990 Significance of apocrine metaplasia in mammary carcinogenesis Ann NY Acad Sci 586: 238–251

    PubMed  CAS  Google Scholar 

  76. Athanassiadou PP, Veneti SZ, Kyrkou KA, Intzes KS, Mouzaka LI, Papadimitriou GK, 1992 Presence of epidermal growth factor receptor in breast smears of cyst fluids: relationship to electrolyte ratios and pH concentration Cancer Detect Prev 16: 113–118

    PubMed  CAS  Google Scholar 

  77. Murad TM, von Haam E, 1968 The ultrastructure of fibrocystic disease of the breast Cancer 22: 587–600

    PubMed  CAS  Google Scholar 

  78. Nagy GK, Jacobs JB, Mason-Savas A, Pomerantz SN, DeCiero GJ, 1989 Intracytoplasmic eosinophilic inclusion bodies in breast cyst fluids are giant lysosomes Acta Cytol 33: 99–103

    PubMed  CAS  Google Scholar 

  79. Simpson JF, Page DL, 1993 Loss of expression of fodrin (a structural protein) in cystic changes of human breast Lab Invest 68: 537–540

    PubMed  CAS  Google Scholar 

  80. Pullinger BD, 1947 Cystic disease of the breast: human and experimental Lancet 2: 567–572

    CAS  PubMed  Google Scholar 

  81. Angeli A, Bradlow HL, Dogliotti L, 1986 Endocrinology of the breast: basic and clinical aspects: Part III-VI Ann NY Acad Sci 464: 100–400

    Google Scholar 

  82. Rosner W, Khan MS, Breed CN, Fleisher M, Bradlow HL, 1985 Plasma steroid-binding proteins in the cysts of gross cystic disease of the breast J Clin Endocrinol Metab 61: 200–203

    PubMed  CAS  Google Scholar 

  83. Angeli A, Dogliotti L, Naldoni C, Orlandi F, Puligheddu B, Caraci P, Bucchi L, Torta M, Bruzzi P, 1994 Steroid biochemistry and categorization of breast cyst fluid: relation to breast cancer risk J Steroid Biochem Molec Biol 49: 333–339

    PubMed  CAS  Google Scholar 

  84. Conway W, Flanagan P, Naughton P, Sharp M, Murray M, O’Higgins N, 1987 The clinical, biochemical and hormonal features of breast cysts Irish Med J 80: 164–166

    CAS  Google Scholar 

  85. Budai B, Szamel I, Sulyok Z, Nemeth M, Bak M, Kralovanszky J, Otto SZ, Besznyak I, Purohit A, Parish DC, Reed MJ, 2000 Influence of hormonal status of patients with cystic disease on the composition of cyst fluid and breast cancer risk Anticancer Res 20: 3879–3886

    PubMed  CAS  Google Scholar 

  86. Fleisher M, Robbins G, Poseed C, Fracchia A, Urban J, Schwartz M, 1973 Biochemistry of breast cyst fluid Meml Sloan Kettering Clin Bull 3: 95

    Google Scholar 

  87. Fleisher M, Bradlow HL, Schwartz MK, Schwartz D, Breed C, 1984 The anion gap in human breast cyst fluid: a possible high risk indicator for breast cancer Clin Chem 30: 940

    Google Scholar 

  88. Bradlow HL, Skidmore FD, Schwartz MK, Fleisher M, 1981 Cation levels in human breast cyst fluid Clin Oncol 7: 388–390

    PubMed  CAS  Google Scholar 

  89. Miller WR, Dixon JM, Scott WN, Forrest APM, 1983 Classification of human breast cysts according to electrolyte and androgen conjugate composition Clin Oncol 9: 227–232

    PubMed  CAS  Google Scholar 

  90. Dogliotti R, Orlandi F, Torta M, Buzzi G, Naldoni C, Mazzotti A, Angeli A, 1986 Cations and dehydroepiandrosterone-sulfate in cyst fluid of pre- and menopausal patients with gross cystic disease of the breast: evidence for the existence of subpopulations of cysts Eur J Cancer Clin Oncol 22: 1301–1307

    PubMed  CAS  Google Scholar 

  91. Boccardo F, Valenti G, Zanardi S, Cerruti G, Fassio T, Bruzzi P, De Franchis V, Barreca A, Del Monte P, Minuto F, 1988 Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content Cancer Res 48: 5860–5863

    PubMed  CAS  Google Scholar 

  92. Suarez B, Vizoso F, Fueyo A, Allende MT, Fernandez Fernandez M, Fdez LLana B, Roiz MC, Ruibal A, 1992 Active androgens in breast cyst fluids Int J Biol Markers 7: 263–264

    PubMed  CAS  Google Scholar 

  93. Sanchez LM, Vizoso F, Allende MT, Ruibal A, Lopez-Otin C, 1992 Quantification and molecular analysis of cathepsin D in breast cyst fluids Eur J Cancer 28: 828–832

    Google Scholar 

  94. Simickova M, Pecen L, Eben K, Nekulova M, Vermousek I, Stratil P, Rejthar A, Cernoch M, Lang B, Sakalova J, 1994 Biochemical analysis of breast cyst fluid as a possible predictor of breast carcinoma development Neoplasma 41: 245–252

    Google Scholar 

  95. Martinez L, Castilla JA, Gil T, Molina J, Diaz MA, Mozas J, Herruzo A, 1995 Intracystic lipidic profile in fibrocystic breast disease Gynecol Endocrinol 8: 287–292

    Google Scholar 

  96. Bicikova M, Szamel I, Hill M, Tallova J, Starka L, 2001 Allopregnanolone, pregnenolone sulphate and epitestosterone in breast cyst fluid Steroids 66: 55–57

    PubMed  CAS  Google Scholar 

  97. Chasalow FI, Bradlow HL, 1990 Digoxin-like materials in human breast cyst fluids Ann NY Acad Sci 586: 107–116

    PubMed  CAS  Google Scholar 

  98. Chasalow FI, Blethen SL, 1990 Characterization of digoxin-like materials in human cord serum Ann NY Acad Sci 595: 212–221

    PubMed  CAS  Google Scholar 

  99. Weber CJ, Kim D, Costanzo M, Morris J, Howe B, Ward L, D’Agati V, McDonald T, O’Dorisio TM, Butler VP Jr., 1994 Relationship of Na and K concentrations to GRP, CGRP and calcitonin immunoreactivities and Na,K-ATPase inhibitory activity in human breast cyst fluid Ann Surg Oncol 1:339–344

    PubMed  CAS  Google Scholar 

  100. Bradlow HL, Breed CN, Nisselbaum J, Fleisher M, Schwartz MK, 1987 pH as a marker of breast cyst fluid biochemical type Eur J Surg Oncol 13: 331–334

    PubMed  CAS  Google Scholar 

  101. Fleisher M, Breed C, Robbins G, Fracchia A, Urban J, Schwartz M, 1976 The elemental composition of human breast cyst fluids Clin Chem 22: 1213

    Google Scholar 

  102. Kanias GD, Kouri E, Arvaniti H, Karaiosifidi H, Kouneli S, 1994 Trace element content in breasts with fibrocystic disease. In: Schrauzer GN Ed., Biological Trace Element Research, Humana Press Inc., Totowa, pp 363–370

    Google Scholar 

  103. Troccoli R, Mannello F, 1992 Improved electrophoretic map of breast cyst fluid proteins Cancer Detect Prev 16: 107–112

    PubMed  CAS  Google Scholar 

  104. Mannello F, Bocchiotti GD, Stocchi O, Gazzanelli G, 1995 Relationship between α1-acid glycoprotein and electrolyte ratio in human breast cyst fluids Eur J Lab Med 1: 51–54

    Google Scholar 

  105. Haagensen DE Jr., Mazoujian G, Dilley WG, Pedersen CE, Kister SJ, Wells SA, 1979 Breast gross cystic disease fluid analysis. I. Isolation and radioimmunoassay for a major component protein J Natl Cancer Inst 62:239–247

    PubMed  Google Scholar 

  106. Dixon JM, Miller WR, Yap PL, Scott WN, Forrest PM, 1983 Further studies on human breast cyst fluids Br J Surg 70: 684

    Google Scholar 

  107. Yap PL, Miller WR, Roberts MM, Creel RJ, Freedman B, Mirtle CL, Pryde EAD, McClelland DBL, 1984 Protein concentrations in fluid from gross cystic disease of the breast Clin Oncol 10: 35–43

    PubMed  CAS  Google Scholar 

  108. Zangerle PF, Spyratos F, Le Doussal V, Noel G, Hacene K, Hendrick JC, Gest J, Franchimont P, 1986 Breast cyst fluid proteins and breast cancer Ann NY Acad Sci 464: 331–349

    PubMed  CAS  Google Scholar 

  109. Balbin M, Vizoso F, Sanchez LM, Venta R, Ruibal A, Fueyo A, Lopez-Otin C, 1991 GCDFP-70 protein in cyst fluid identified as albumin and used to classify cysts in women with breast gross cystic disease Clin Chem 37: 547–551

    PubMed  CAS  Google Scholar 

  110. Duncan LJ, Robinson GV, Ghilchik MW, Reed MJ, 1994 The effect of gross cystic disease fluid proteins on oestrogen synthesis in breast cancer cells Endocrine-Related Cancer 2: 27–35

    Google Scholar 

  111. Mannello F, Malatesta M, Bocchiotti GD, Gazzanelli G, 1994 α1-Antichymotrypsin complexes in human breast cyst fluids Cancer Lett 76: 155–159

    PubMed  CAS  Google Scholar 

  112. Biagioni S, Stella F, Mannello F, Cerroni L, Stella C, Troccoli R, 1985 α1-Antitrypsin, transferrin, alkaline phosphatase, phosphohexoseisomerase and γ-glutamyltransferase in breast cyst fluid Tumori 71: 135–140

    PubMed  CAS  Google Scholar 

  113. Pearlman WH, Gueriguian JL, Sawyer ME, 1973 A specific progesterone-binding component of human breast cyst fluid J Biol Chem 248: 5736–5741

    PubMed  CAS  Google Scholar 

  114. Pearlman WH, Peng LH, Mazoujian G, Haagensen DE Jr., Wells SA Jr., Kister SJ, 1977 A specific progesterone binding component of human breast cyst fluid: its isolation and characterization J Endocrinol 75: 19–20

    Google Scholar 

  115. Dilley WG, Haagensen DE, Cox CE, Wells SA Jr., 1990 Immunologic and steroid binding properties of the GCDFP-24 protein isolated from human breast gross cystic disease fluid Breast Cancer Res Treat 16: 253–260

    PubMed  CAS  Google Scholar 

  116. Balbin M, Freije JMP, Fueyo A, Sanchez LM, Lopez-Otin C, 1990 Apolipoprotein D is the major protein component in cyst fluid from women with human breast gross cystic disease Biochem J 271: 803–807

    PubMed  CAS  Google Scholar 

  117. Sanchez LM, Diez-Itza I, Vizoso F, Lopez-Otin C, 1992 Cholesterol and apolipoprotein D in gross cystic disease of the breast Clin Chem 38: 695–698

    PubMed  CAS  Google Scholar 

  118. Witkin SS, Sarkar NH, Kinne DW, Breed CN, Good RA, Day NK, 1981 Antigens and antibodies cross-reactive to the murine mammary tumor virus in human breast cyst fluids J Clin Invest 67: 216–222

    PubMed  CAS  Google Scholar 

  119. Takahashi K, Lai LC, Ghatei MA, James VHT, Bloom SR, 1990 Endothelin-like immunoreactivity in human breast cyst fluid J Clin Endocrinol Metab 71: 1681–1683

    PubMed  CAS  Google Scholar 

  120. Lai LC, Ghatei MA, Takahashi K, Patel KV, Schrey MP, Ghilchik MW, Bloom SR, James VHT, 1990 Mitogenic peptides in breast cyst fluid: relationship with intracystic electrolyte ratios Int J Cancer 46: 1014–1016

    PubMed  CAS  Google Scholar 

  121. Lai LC, Siraj AK, Kadory S, Lennard TWJ, 1995 Concentrations of soluble vascular cell adhesion molecule-1 and E-selectin in breast cyst fluid and their relation with cyst type Br J Surg 82: 83–85

    PubMed  CAS  Google Scholar 

  122. Troccoli R, Stella F, Biagioni S, Battistelli S, Cerroni L, Marcheggiani F, Artico M, Terzano C, Mannello F, 1990 Ferritin and transferrin levels in human breast cyst fluids: relationship with intracystic electrolyte concentrations Clin Chim Acta 192: 1–8

    PubMed  CAS  Google Scholar 

  123. Collette J, Hendrick JC, Jaspar JM, Franchimont P, 1986 Presence of α-lactalbumin, epidermal growth factor, epithelial membrane antigen and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid Cancer Res 46: 3728–3733

    PubMed  CAS  Google Scholar 

  124. Mazoujian G, Warhol MJ, Haagensen DE Jr., 1984 The ultrastructural localization of gross cystic disease fluid protein (GCDFP-15) in breast epithelium Am J Pathol 116: 305–310

    PubMed  CAS  Google Scholar 

  125. Vandewalle B, Hornez L, Vennin P, Peyrat JP, Lefebvre J, 1986 Further characterization of the light breast cyst fluid protein, GCDFP-15 Biochimie 68: 649–656

    PubMed  CAS  Google Scholar 

  126. Haagensen DE Jr., Dilley WG, Mazoujian G, Wells SA Jr., 1990 Review of GCDFP-15 Ann NY Acad Sci 586: 161–173

    PubMed  Google Scholar 

  127. Agrimonti F, Cavallo R, Frairia R, Violino PL, Borretta G, Angeli A, 1982 Immunoglobulin levels in breast cyst fluid: apparent connection with intracystic transcortin binding activity Boll Ist Sieroter Milan 61: 44–50

    PubMed  CAS  Google Scholar 

  128. Mannello F, Battistelli S, Bocchiotti GD, Marcheggiani F, Troccoli R, 1991 Circulating immune complexes in human breast cyst fluids: relationship with intracystic immunoglobulin and electrolyte levels Int J Biol Markers 6: 122–127

    PubMed  CAS  Google Scholar 

  129. Reed MJ, Coldham NG, Patel SR, Ghilchik MW, James VHT, 1992 Interleukin-1 and interleukin-6 in breast cyst fluid: their role in regulating aromatase activity in breast cancer cells J Endocrinol 132: 5–8

    Google Scholar 

  130. Lai LC, Kadory S, Cornell C, Lennard TWJ, 1993 Possible regulation of soluble ICAM-1 levels by interleukin-1 in a subset of breast cysts Int J Cancer 55: 586–589

    PubMed  CAS  Google Scholar 

  131. Lai LC, Kadory S, Siraj AK, Lennard TWJ, 1994 Oncostatin, interleukin-2, interleukin-6 and interleukin-8 in breast cyst fluid Int J Cancer 59: 369–372

    PubMed  CAS  Google Scholar 

  132. Lai LC, Chan CTM, Cornell C, Lennard TWJ, 1993 Growth inhibitory substances in human breast cyst fluid Anticancer Res 13: 225–228

    PubMed  CAS  Google Scholar 

  133. Le Doussal V, Zangerle PF, Collette J, Spyratos F, Hacene K, Briere M, Gest J, Franchimont P. 1984 Immunohistochemical detection of alpha-lactalbumin in breast lesions Eur J Cancer Clin Oncol 20: 1069–1078

    PubMed  CAS  Google Scholar 

  134. Miller WR, Dawes J, 1985 Platelet-associated proteins in human breast cyst fluids Clin Chim Acta 152: 37–42

    PubMed  CAS  Google Scholar 

  135. Macgregor IR, Miller WR, 1988 Urokinase and tissue-type plasminogen activators are present in breast cyst fluids Eur J Cancer Clin Oncol 24: 985–989

    PubMed  CAS  Google Scholar 

  136. Lai LC, Cornell C, Lennard TWJ, 1993 Relationship between oestrogen-inducible proteins, estradiol and electrolyte ratio in breast cyst fluid Cancer Lett 69: 21–25

    PubMed  CAS  Google Scholar 

  137. Hayden K, Tetlow L, Byrne G, Bundred N: Radioimmunoassay for the measurement of thrombospondin in plasma and breast cyst fluid: validation and clinical application. Ann Clin Biochem 37: 319–325

  138. Frairia R, Agrimonti F, Barbadoro E, Fazzari A, Boccuzzi G, Angeli A, 1983 Evidence for a transcortin-like component in human breast cyst fluid Clin Chim Acta 131: 15–27

    PubMed  CAS  Google Scholar 

  139. Haagensen DE, Mazoujian G, 1983 Utilization of the GCDFP-15 protein as a marker of breast carcinomas with apocrine features: clinical and pathological findings Protides Biol Fluids 31: 567–570

    Google Scholar 

  140. Haagensen DE, Kelly D, Bodian CA, 1997 GCDFP-15 blood levels for stratification of risk of breast cancer development in women with active breast gross cystic disease Breast 6: 113–119

    Google Scholar 

  141. Sapino A, Cassoni P, Bussolati G, 2000 Gross cystic disease fluid protein (GCDFP-15) in the breast: past and present J Biol Regul Homeost Agents 14: 259–262

    PubMed  CAS  Google Scholar 

  142. Mannello F, Troccoli R, Battistelli S, Marcheggiani F, 1990 Acid phosphatases in breast cyst fluids Progr Med Lab 4: 473

    Google Scholar 

  143. Schwartz MK, Schwartz DC, 1984 Enzyme concentrations in breast cyst fluid and in cytosols of human breast tissue Progr Med Lab 11: 39–40

    Google Scholar 

  144. Frame KL, Patton K, Reed MJ, Ghilchik MW, Parish DC, 1996 Angiotensin-converting enzyme and enkephalinase in human breast cyst fluid Br J Cancer 74: 807–813

    PubMed  CAS  Google Scholar 

  145. Kesner L, Yu W, Bradlow HL, Breed CW, Fleisher M, 1988 Proteases in cyst fluid from human gross cyst breast disease Cancer Res 48: 6379–6383

    PubMed  CAS  Google Scholar 

  146. Scambia G, Benedetti Panici P, Ferrandina G, Battaglia F, Rossi S, Bellantone R, Crucitti F, Mancuso S, 1991 Cathepsin D and epidermal growth factor in human breast cyst fluid Br J Cancer 64: 965–967

    PubMed  CAS  Google Scholar 

  147. Banerjee S, Katz J, Levitz M, Finlay TH, 1990 Identification of a novel esterase in human breast cyst fluid Ann NY Acad Sci 586: 204–212

    PubMed  CAS  Google Scholar 

  148. Banerjee S, Katz J, Levitz M, Finlay TH, 1991 Purification and properties of an esterase from human breast cyst fluid Cancer Res 51: 1092–1098

    PubMed  CAS  Google Scholar 

  149. Levitz M, Raju U, Katz J, Finlay TH, Brind JL, Arcuri F, Castagnetta L, 1992 Esterase activity in human breast cyst fluid: associations with steroid sulphates and cations. Steroids 57: 485–487

    PubMed  CAS  Google Scholar 

  150. Magklara A, Scorilas A, Lopez-Otin C, Vizoso F, Ruibal A, Diamandis EP, 1999 Human glandular kallikrein in breast milk, amniotic fluid and breast cyst fluid Clin Chem 45: 1774–1780

    PubMed  CAS  Google Scholar 

  151. Minton JP, Walaszek Z, Schooley W, Hanausek-Walaszek M, Webb TE, 1986 β-glucuronidase levels in patients with fibrocystic breast disease Breast Cancer Res Treat 8: 217–222

    PubMed  CAS  Google Scholar 

  152. Fleisher M, 1990 The biochemical composition of human breast cyst fluid: the assessment of risk factors for breast cancer Clin Chem 36: 1236

    Google Scholar 

  153. Mannello F, Stocchi O, Pazzaglia E, Troccoli R, 1990 γ-glutamyltransferase expression in human breast cyst fluids Progr Med Lab 4: 474

    Google Scholar 

  154. Diamandis EP, Yousef GM, Soosaipillai AR, Grass L, Porter A, Little S, Sotiropoulou G., 2000 Immunofluorimetric assay of human kallikrein 6 (zyme, protease M/neurosin) and preliminary clinical applications Clin Biochem 33: 369–375

    PubMed  CAS  Google Scholar 

  155. Biagioni S, Mannello F, Stella F, Battistelli S, Marcheggiani F, Cerroni L, Artico M, Terzano C, Troccoli R, 1987. Lactate dehydrogenase, isoenzyme patterns and cation levels in human breast gross cyst fluid Clin Chim Acta 169: 91–98

    PubMed  CAS  Google Scholar 

  156. Vizoso F, Allende MT, Fdez Fdez M, Suarez B, Fdez LLana B, Roiz MC, Ruibal A, 1992. Total lactate dehydrogenase and tumor necrosis factor alpha levels in cyst fluid of women with gross cystic breast disease Int J Biol Markers 7: 123–125

    PubMed  CAS  Google Scholar 

  157. Mannello F, Bocchiotti GD, Pignatti Morano F, Fratepietro LM, Gazzanelli G, 1996. Lipids status in human breast cyst fluids Cancer Lett 98: 137–143

    PubMed  CAS  Google Scholar 

  158. Sanchez LM, Freije JP, Merino AM, Vizoso F, Foltmann B, Lopez-Otin C. 1992. Isolation and characterisation of a pepsin C zymogen produced by human breast tissues J Biol Chem 267: 24725–24731

    PubMed  CAS  Google Scholar 

  159. Diamandis EP, Nadkarni S, Bhaumik B, Abdelrahman A, Melegos DN, Borchert G, Black MH, Alonso M, Salas A, de lo Toyos JR, Sampedro A, Lopez-Otin C. 1997. Immunofluorimetric assay of pepsinogen C and preliminary clinical applications Clin Chem 43: 1365–1371

    PubMed  CAS  Google Scholar 

  160. Borchert GH, Melegos DN, Yu H, Giai M, Roagna R, Ponzone R, Sgro L, Diamandis EP, 1999. Quantification of pepsinogen C and prostaglandin D synthase in breast cyst fluid and their potential utility for cyst type classification Clin Biochem 32: 39–44

    PubMed  CAS  Google Scholar 

  161. Melegos DN, Diamandis EP, Oda H, Urade Y, Hayaishi O, 1996. Immunofluorimetric assay of prostaglandin D synthase in human tissue extracts and fluids Clin Chem 42: 1984–1991

    PubMed  CAS  Google Scholar 

  162. Malatesta M, Mannello F, Sebastiani M, Bianchi G, Gazzanelli G, 1999. Prostate-specific antigen found in Type I breast cyst fluids is a secretory product of the apocrine cells lining breast gross cysts Breast Cancer Res Treat 57: 157–163

    PubMed  CAS  Google Scholar 

  163. Mannello F, Bocchiotti GD, Bianchi G, Marcheggiani F, Gazzanelli G, 1996. Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids Breast Cancer Res Treat 38: 247–252

    PubMed  CAS  Google Scholar 

  164. Diamandis EP, Yu H, Lopez-Otin C, 1996. Prostate-specific antigen: a new constituent of breast cyst fluid Breast Cancer Res Treat 38: 259–264

    PubMed  CAS  Google Scholar 

  165. Lai LC, Erbas H, Lennard TWJ, Peaston RT, 1996. Prostate-specific antigen in breast cyst fluid: possible role of PSA in hormone-dependent breast cancer Int J Cancer 66: 743–746

    PubMed  CAS  Google Scholar 

  166. Filella X, Molina R, Alcover J, Carretero P, Ballesta AM, 1996. Detection of nonprostatic PSA in serum and nonserum samples from women Int J Cancer 68: 424–427

    PubMed  CAS  Google Scholar 

  167. Filella X, Molina R, Alcover J, Menendez V, Gimenez N, Jo J, Carretero P, Ballesta AM, 1996. Prostate-specific antigen detection by ultrasensitive assay in samples from women Prostate 29: 311–316

    PubMed  CAS  Google Scholar 

  168. Mannello F, Sebastiani M, Amati S, Gazzanelli G, 1997. Prostate-specific antigen expression in a case of intracystic carcinoma of the breast: characterisation of immunoreactive protein and literature survey Clin Chem 43:1448–1454

    PubMed  CAS  Google Scholar 

  169. Borchert GH, Yu H, Tomlinson G, Giai M, Roagna R, Ponzone R, Sgro L, Diamandis EP, 1999. Prostate-specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease J Clin Lab Anal 13: 75–81

    PubMed  CAS  Google Scholar 

  170. Mannello F, Malatesta M, Sebastiani M, Gazzanelli G, 2001. Differential distribution of soluble and complexed forms of prostate-specific antigen in cyst fluids of women with gross cystic breast disease J Clin Lab Anal 15: 81–86

    PubMed  Google Scholar 

  171. Mannello F, Gazzanelli G, 2001. Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics? Breast Cancer Res 3: 238–243

    PubMed  CAS  Google Scholar 

  172. Diamandis EP, 2000. Prostate-specific antigen: a cancer fighter and a valuable messenger? Clin Chem 46: 896–900

    PubMed  CAS  Google Scholar 

  173. Martinez L, Castilla JA, Blanco N, Peran F, Herruzo A, 1995. CA 125, CA 15.3, CA 27.29, CEA, β-hCG and α-fetoprotein levels in cyst fluid of breast macrocysts Int J Gynecol Obstet 48: 187–192

    CAS  Google Scholar 

  174. Vizoso F, Allende MT, Fueyo A, Vigal G, Garcia-Moran M, Ruibal A, 1989. CA 15.3 behaviour in cystic breast disease Int J Biol Markers 4: 181–182

    PubMed  CAS  Google Scholar 

  175. Inaudi P, De Leo V, Baldini S, D’Antona N, 1990. Adrenal steroids and tumor antigens in plasma and cyst fluid of women with gross cystic breast disease Ann NY Acad Sci 586: 117–120

    PubMed  CAS  Google Scholar 

  176. Luciani S, Carenza L, Pala A, Amelio G, Cascialli G, Pirozzi F, Pozzi M, Pozzi V, 1990. Evaluation of tumor and trophoblastic marker concentration in breast cyst fluid Ann NY Acad Sci 586: 218–229

    PubMed  CAS  Google Scholar 

  177. Fleisher M, Oettgen HF, Breed CN, Robbins GF, Pinsky CM, Schwartz MK, 1974. CEA-like material in fluid from benign cysts of the breast Clin Chem 20: 41–42

    PubMed  CAS  Google Scholar 

  178. Olivati S, Cappellari A, Bagarella M, Corradi G, Zago L, Martinelli D, 1986. Carcinoembryonic antigen (CEA) in human breast cyst fluid: a study of 101 cases Ann NY Acad Sci 464: 599

    Google Scholar 

  179. Matsuo S, Eto T, Soejima H, Ohara O, Hidaka O, Miyazaki J, Tsunoda T, Kanematsu T, 1993. A case of intracystic carcinoma of the breast: the importance of measuring carcinoembryonic antigen in aspirated cystic fluid Breast Cancer Res Treat 28: 41–44

    PubMed  CAS  Google Scholar 

  180. Inaji H, Koyama H, Motomura K, Noguchi S, Tsuji N, Kimura Y, Sato H, Sugano K, Ohkura H, 1994. Simultaneous assay of erbB-2 protein and carcinoembryonic antigen in cyst fluid as an aid in diagnosing cystic lesions of the breast Breast Cancer 1: 25–30

    PubMed  Google Scholar 

  181. Secreto G, Recchione C, Fariselli G, Grignolio E, Di Pietro S, 1984. Circulating levels and breast cyst fluid concentrations of human chorionic gonadotropin, progesterone and testosterone in women with gross cystic breast disease Tumori 70: 523–527

    PubMed  CAS  Google Scholar 

  182. Abney TO, Mullins WB, Teran AZ, Greenblatt RB, Mahesh VB, 1988. Fibrocystic breast disease: the significance of β-human chorionic gonadotropin and other polypeptides in breast cyst fluid Fertil Steril 49: 638–643

    PubMed  CAS  Google Scholar 

  183. Troccoli R, Battistelli S, Marcheggiani G, Sessa M, Fronduti A, 1990. Levels of human chorionic gonadotropin in breast cyst fluid Int J Biol Markers 5: 133–136

    PubMed  CAS  Google Scholar 

  184. Schurz B, Schon HJ, Wenzl R, Kubista E, Spona J, Huber J, 1991. Breast cyst fluid concentrations of β-endorphin, steroids and gonadotropins in premenopausal women with gross cystic disease Maturitas 13: 123–127

    PubMed  CAS  Google Scholar 

  185. Enriori PJ, Hirsig RJP, Vico CM, Etkin AE, Negri JC, Enriori CL, 2000. Effect of natural micronized progesterone on the chorionic gonadotropin concentrations in cyst fluids of women with gross cystic breast disease J Steroid Biochem Mol Biol 73: 67–70

    PubMed  CAS  Google Scholar 

  186. Mezi S, Reale MG, Aloise G, Marigliani A, Marchei CG, Sallusti E, Mentuccia D, DelNero A, Izzo P, Modesti M, 1999. The intracystic concentration of MCA in the fluid from large breast cysts G Chir 20: 246–251

    PubMed  CAS  Google Scholar 

  187. Mannello F, Bocchiotti GD, Troccoli R, 1991. Tissue-polypeptide specific antigen in human breast cyst fluids Eur J Cancer 27 (Suppl 3): S80

    Google Scholar 

  188. Alvarez A, Martinez Rodriguez PI, Nunez MI, Alba A, Allende MT, Ruibal AM, 1995. TPS cytosolic levels in non-malignant breast diseases Int J Biol Markers 10: 183–184

    PubMed  CAS  Google Scholar 

  189. Vizoso F, Allende MT, Fernandez R, Suarez B, Diez MC, Ruibal A, 1991. High TAG-72 serum levels, defined by MoAb B72.3, in premenopausal women with benign breast disease, are associated with Type I gross cystic disease Int J Biol Markers 6: 197–198

    PubMed  CAS  Google Scholar 

  190. Beczassy E, Szamel I, Sulyok Z, Otto S, 2000. Tumour markers in human breast cyst fluid in gross cystic breast disease (GCBD) Magy Onkol 44: 65–67

    PubMed  Google Scholar 

  191. Lai LC, Siraj AK, Erbas H, Lennard TWJ, 1995. Relationship between basic fibroblast growth factor and transforming growth factor-beta 2 in breast cyst fluid J Clin Endocrinol Metab 80: 711–714

    PubMed  CAS  Google Scholar 

  192. Jaspar JM, Franchimont P, 1985. Radioimmunoassay of human epidermal growth factor in human breast cyst fluid Eur J Cancer Clin Oncol 21: 1343–1348

    PubMed  CAS  Google Scholar 

  193. Lai LC, Dunkley SA, Reed MJ, Ghilchik MW, James VH, 1989. Estradiol and epidermal growth factor in breast cyst fluid Anticancer Res 9: 1853–1856

    PubMed  CAS  Google Scholar 

  194. Lai LC, Ghilchik MW, Shaikh NA, Reed MJ, James VHT, 1989. Relationship between epidermal growth factor and dehydroepiandrosterone and its sulphate in breast cyst fluid Br J Cancer 60: 320–323

    PubMed  CAS  Google Scholar 

  195. Smith K, Miller WR, Fennelly JA, Matthews JNS, Scott WN, Harris AL, 1989. Quantification of epidermal growth factor in human breast fluids: correlation with dehydroepiandrosterone-sulphate and electrolyte concentrations Int J Cancer 44: 229–232

    PubMed  CAS  Google Scholar 

  196. Wang DY, Hamed H, Mockridge CI, Fentiman IS, 1989. Radioimmunoassayable insulin-like growth factor-I in human breast cyst fluid Eur J Cancer Clin Oncol 25: 867–872

    PubMed  CAS  Google Scholar 

  197. Boccardo F, Zanardi S, Valenti G, Cannata D, Maisto L, Nicolò G, Barreca A, Del Monte P, Minuto F, 1990. Epidermal growth factor in breast cyst fluids Ann NY Acad Sci 586: 137–142

    PubMed  CAS  Google Scholar 

  198. Collette J, Van Cauwenberge JR, Dejardin L, Carlisi A, Jaspar JM, Franchimont P, 1990. Epidermal growth factor and prolactin in human breast cyst fluid: possible correlations with GCDFP-15 Ann NY Acad Sci 586:146–157

    PubMed  CAS  Google Scholar 

  199. Lai LC, Dunkley SA, Reed MJ, Ghilchik MW, Shaikh NA, James VHT, 1990. Epidermal growth factor and oestradiol in human breast cyst fluid Eur J Cancer 26: 481–484

    PubMed  CAS  Google Scholar 

  200. Tapper D, Gajdusek C, Moe R, Ness J, 1990. Identification of a unique biological tumor marker in human breast cyst fluid and breast cancer tissue Am J Surg 159: 473–478

    PubMed  CAS  Google Scholar 

  201. Wang DY, Hamed H, Fentiman IS, 1990, Epidermal growth factor and insulin-like growth factor I in human breast cyst fluid Ann NY Acad Sci 586:158–160

    PubMed  CAS  Google Scholar 

  202. Hamed H, Wang DY, Moore JW, Clark GMG, Fentiman IS, 1990. Growth factor and electrolyte concentration in human breast cyst fluid Eur J Cancer 26: 479–480

    Article  PubMed  CAS  Google Scholar 

  203. Boccardo F, Torrisi R, Zanardi S, Valenti G, Pensa F, De Franchis V, Barreca A, Ferraro P, Minuto F. 1991. EGF in breast cyst fluid: relationships with intracystic androgens, estradiol and progesterone Int J Cancer 47: 523–526

    PubMed  CAS  Google Scholar 

  204. Ness JC, Sedghinasab M, Moe RE, Tapper D, 1993. Identification of multiple proliferative growth factors in breast cyst fluid Am J Surg 166: 237–243

    PubMed  CAS  Google Scholar 

  205. Hess JC, Sedghinasab M, Moe RE, Pearce LA, Tapper D, 1994. Growth factor profiles in breast cyst fluid identify women with increased breast cancer risk Am J Surg 167: 523–530

    PubMed  CAS  Google Scholar 

  206. Zanardi S, Pensa F, Torrisi R, De Franchis V, Barreca A, Minuto F, Boccardo F, 1994. Presence of immunoassayable transforming growth factor-β1 (TGF-β1) in breast cyst fluid (BCF): relationship with the intracystic electrolyte and epidermal growth factor (EGF) content Int J Cancer 59: 725–727

    PubMed  CAS  Google Scholar 

  207. Torrisi R, Zanardi S, Pensa F, Valenti G, De Franchis V, Nicolo G, Barreca A, Minuto F, Boccardo F, 1995. Epidermal growth factor content of breast cyst fluid from women with breast cancer or proliferative disease of the breast Breast Cancer Res Treat 33: 219–224

    PubMed  CAS  Google Scholar 

  208. Zanardi S, Pensa F, Torrisi R, De Franchis V, Barreca A, Minuto F, Boccardo F, 1996. Presence and distribution of growth factors in breast cyst fluid Ann NY Acad Sci 784: 542–549

    PubMed  CAS  Google Scholar 

  209. Boccardo F, Marenghi C, Ghione G, Pepe A, Parodi S, Rubagotti A, 2001. Intracystic epidermal growth factor level is predictive of breast cancer risk in women with gross cystic disease of the breast Int J Cancer 95: 260–265

    PubMed  CAS  Google Scholar 

  210. Boccardo F, Lunardi GL, Petti AR, Rubagotti A, 2003. Enterolactone in breast cyst fluid: correlation with EGF and breast cancer risk Breast Cancer Res Treat 79: 17–23

    PubMed  CAS  Google Scholar 

  211. Lai LC, Erbas H, Meadows KA, Lennard TWJ, Holly JMP, 1996. Insulin-like growth factor binding protein-3 in breast cyst fluid: relationships with insulin-like growth factors I and II and transforming growth-beta 1 and 2 Cancer Lett 11: 207–212

    Google Scholar 

  212. Lai LC, Siraj AK, Erbas H, Lennard TWJ, 1994. Transforming growth factor alpha, beta 1 and beta 2 in breast cyst fluid Anticancer Res 14: 2805–2810

    PubMed  CAS  Google Scholar 

  213. Ruibal A, Nunez MI, Schneider J, Del Rio MC, Rabadan F, Tejerina A, 1998 Transforming growth factor beta 2 (TGFbeta2) and dehydroepiandrosterone sulphate (DHEAs) levels in breast macrocyst fluids: different behaviour according to cyst type Int J Biol Markers 13: 173–175

    PubMed  CAS  Google Scholar 

  214. Erbas H, Lennard TW, Lai LC, 1999. Latent forms of transforming growth factor-beta 2 (TGF-beta2) in breast cyst fluid Anticancer Res 19: 3077–3082

    PubMed  CAS  Google Scholar 

  215. Herruzo A, Castilla JA, Ramirez A, Marcos C, Menjon S, 1999. Tumor necrosis factor-alpha and interleukin-1 and -6 in fibrocystic breast disease Breast Cancer Res Treat 54: 159–164

    PubMed  CAS  Google Scholar 

  216. Mannello F, Bocchiotti GD, Troccoli R, Gazzanelli G. 1992. Lipid-associated sialic acid levels in human breast cyst fluids Breast Cancer Res Treat 24: 167–170

    PubMed  CAS  Google Scholar 

  217. Baker PR, Reid AD, Siow Y, Preece PE, 1986. Bile acids in human breast cyst fluid Biochem Soc Trans 14: 962–964

    CAS  Google Scholar 

  218. Baker PR, Reid AD, Siow Y, Baty JD, Willis RG, 1986. Identification of bile acids in breast cyst fluid Biochem Soc Trans 16: 741–742

    CAS  Google Scholar 

  219. Raju U, Levitz M, Javitt NB, 1990. Bile acids in human breast cyst fluid: the identification of lithocholic acid J Clin Endocrinol Metab 70: 1030–1034

    PubMed  CAS  Google Scholar 

  220. Javitt NB, Budai K, Miller DG, Cahan AC, Raju U, Levitz M, 1994. Breast-gut connection: origin of chenodeoxycholic acid in breast cyst fluid Lancet 343: 633–635

    PubMed  CAS  Google Scholar 

  221. Schon HJ, Schurz B, Wenzl R, Knogler W, Kubista E, 1993 β-endorphin, steroids and prolactin Arch Pathol Lab Med 117: 248–253

    PubMed  CAS  Google Scholar 

  222. Mannello F, Bocchiotti GD, Mezzolani MP, Gazzanelli G, 1995. β-endorphin expression in gross cystic breast disease Cancer Lett 89: 189–193

    PubMed  CAS  Google Scholar 

  223. Tallova J, Tomandl J, Bicickova M, Simickova M, 2001. Homocysteine in breast cyst fluid Eur J Clin Invest 31: 623–627

    PubMed  CAS  Google Scholar 

  224. Zhang SM, Willett WC, Selhub J, Hunter DJ, Giovannucci EL, Holmes MD, Colditz GA, Hankinson SE, 2003. Plasma folate, vitamin B6 and B12, homocysteine and risk of breast cancer J Natl Cancer Inst 95: 373–380

    PubMed  CAS  Google Scholar 

  225. Weber CJ, O’Dorisio TM, McDonald TJ, Howe B, Koschitzky T, Merriam L, 1989. Gastrin-releasing peptide-, calcitonin gene-related peptide-, and calcitonin-like immunoreactivity in human breast cyst fluid and gastrin-releasing peptide-like immunoreactivity in human breast carcinoma cell lines Surgery 106: 1134–1140

    PubMed  CAS  Google Scholar 

  226. Cassoni P, Sapino A, Haagensen DE, Naldoni C, Bussolati G, 1995. Mitogenic effect of the 15-kDa gross cystic disease fluid protein (GCDFP-15) on breast cancer cell lines and on immortal mammary cells Int J Cancer 60: 216–220

    Article  PubMed  CAS  Google Scholar 

  227. Arzimanoglou II, Sekeris CE, Vassilaros S, 1988. Absence of in vitro mutagenicity of the fluid from breast cysts of women with macrocystic disease J Cancer Res Clin Oncol 114: 215–216

    PubMed  CAS  Google Scholar 

  228. Scott WN, Miller WR, 1991. Mutagens in human breast cyst fluid J Cancer Res Clin Oncol 117: 254–258

    PubMed  CAS  Google Scholar 

  229. Mannello F, Sebastiani M, 2003. Zymographic analyses and measurements of matrix metalloproteinase-2 and -9 in nipple aspirate fluids Clin Chem 49: 1546–1550

    PubMed  CAS  Google Scholar 

  230. Ohta T, Fukuda M, 2004. Ubiquitin and breast cancer Oncogene 23: 2079–2088

    PubMed  CAS  Google Scholar 

  231. Carr KM, Rosenblatt K, Petricoin EF, Liotta LA, 2004. Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy Human Genomics 1: 134–140

    PubMed  CAS  Google Scholar 

  232. Lopez-Otin C, Overall CM, 2002. Protease degradomics: a new challenge for proteomics Nat Rev Mol Cell Biol 3: 509–519

    PubMed  CAS  Google Scholar 

  233. Shin BK, Wang H, Hanash S, 2002. Proteomics approaches to uncover the repertoire of circulating biomarkers for breast cancer J Mammary Gland Biol Neoplasia 7: 407–413

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ferdinando Mannello.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mannello, F., Tonti, G.A.M. & Papa, S. Human gross cyst breast disease and cystic fluid: bio-molecular, morphological, and clinical studies. Breast Cancer Res Treat 97, 115–129 (2006). https://doi.org/10.1007/s10549-005-9110-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-005-9110-y

Keywords

Navigation